Biovista Announces Research Collaboration With a Major Pharmaceutical Company

April 27, 2011Press Releases

CHARLOTTESVILLE, Virginia, April 27, 2011 /PRNewswire/ — Biovista announced today that it has entered into a research collaboration agreement with Novartis. The collaboration is focused on identifying new indications for a number of undisclosed Novartis compounds using Biovista’s Clinical Outcome Search Space (COSS) technology. The terms of the agreement include an upfront payment and success-based … Read More

Biovista Announces a Drug Repositioning Collaboration With Pfizer

November 9, 2010Press Releases

CHARLOTTESVILLE, Virginia, November 9, 2010 /PRNewswire/ — Biovista announced today that it has entered into a pilot research collaboration agreement with Pfizer (Pfizer Inc. (NYSE: PFE). The aim of the collaboration is to identify new indications for a number of undisclosed Pfizer development candidates, using Biovista’s Clinical Outcome Search Space (COSS) technology. Under the terms … Read More

Biovista Inc. and FDA to Collaborate on a Medication Safety Initiative

January 12, 2010Press Releases

CHARLOTTESVILLE, Virginia, January 12 /PRNewswire/ — Biovista Inc. today announced that the U.S. Food and Drug Administration (FDA) has licensed its technology platform to help analyze, identify, and better understand the way certain drugs can cause harmful side effects. The FDA’s Office of Clinical Pharmacology, within the Center for Drug Evaluation and Research (CDER), will … Read More